TFFP News and Press, TFF Pharmaceuticals Inc - Ordinary Shares From 11/23/22

Are These Penny Stocks A Buy Now? Here’s What Insiders Think Since penny stocks are so cheap, traders tend to treat them more like lotto tickets than actual investments. Sure, they tend to present much more opportunity in the short term. But that doesn’t mean people aren&#...

FORT WORTH, Texas, Nov. 18, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced th...

FORT WORTH, Texas, Nov. 17, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced th...

TFF Pharmaceuticals, Inc. (TFFP) Q3 2022 Earnings Conference Call November 14, 2022, 17:00 ET Company Participants Corey Davis - LifeSci Advisors Glenn Mattes - President, CEO & Director Dale Christensen - Head, Clinical Development Kirk Coleman - CFO, Tr...

TFF Pharmaceuticals press release ( NASDAQ: TFFP ): Q3 GAAP EPS of -$0.29 beats by $0.04 . Revenue of $0.09M (+80.0% Y/Y). For further details see: TFF Pharmaceuticals GAAP EPS of -$0.29 beats by $0.04, revenue of $0.09M

Clinical Proof-of-Concept Demonstrated in Compassionate Use in Two Case Studies with Voriconazole Inhalation Powder (TFF VORI) Growing Body of Peer-Reviewed Scientific Literature Provides Foundations for Expanding Applications of Thin Film Freezing Feasibility Study ...

Company conference call and webcast at 4:30 PM ET FORT WORTH, Texas, Nov. 07, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented T...

Administration of dry powders will utilize Aptar Pharma’s Unidose (UDS) Powder Nasal Spray System The TFF dry powder vaccines maintain the antigen’s integrity, can be delivered to the targeted region of the nasal cavity, and have desirable particle size distrib...

TFF Pharmaceuticals ( NASDAQ: TFFP ), a company focused on inhaled dry powder drugs, dropped ~39% pre-market Wednesday after revising its plans to share early Phase 2 clinical results for lead assets Voriconazole (TFF VORI) and Tacrolimus (TFF TAC). Citing issues ...

Marks the Second Patient to Clinically Benefit from Administration of Voriconazole Inhalation Powder (TFF VORI) Using Thin Film Freezing-Based Technology Positive Results from First Patient Treated with TFF VORI Recently Presented at the 15th Annual International Congress on Lun...